Other companies with potential vaccine changes include Pune-based Gennova Biopharmaceuticals and Hyderabad-based BioE. Both will start injections in the coming months.
Novavax said on Monday that it has already begun developing a new recombinant peplomer based on the known sequence of B.1.1.529 and is ready to begin testing and manufacturing within the next few weeks. I did. “We will continue to work urgently to address this latest strain and the continued evolution of Covid-19,” said a company official. TOI..
Experts believe that companies are “likely” likely to need to return to the first stage, but “final” based on data on transmissibility and the effectiveness of existing vaccines against new variants. Take a good view.
“Today we do not know the effectiveness of existing vaccines against this virus. Companies need to develop strategies to fight this virus by reinventing the vaccine against this new sequence. “The domestic vaccine player said on condition of anonymity.
Kirill Dmitriev, CEO of the Russian Direct Investment Fund, which supports Sputnik V, said: If changes are needed, we will provide hundreds of millions of Sputnik Omicron boosters by February 20th. “
The company was confident that it would quickly adapt to the new tensions in the technology platform in use. “Novavax’s recombinant nanoparticle technology allows us to adapt rapidly to strain changes and help induce antibodies that are broadly cross-neutralized based on the use of full-length peplomer,” the company said.
New variants could force pharmaceutical companies to tweak Covid vaccination plans, Health News, and ET Health World
Source link New variants could force pharmaceutical companies to tweak Covid vaccination plans, Health News, and ET Health World